Hi im new to this thread but long term stock player also I got a...

Hi im new to this thread but long term stock player also I got a following. I've done my resreach and like NEU. But im a luddite/newbie in Bio tech-i was turned onopt this (and IMU) buy a guy at my gym. I bought some months ago at the 3.15 level and have been watching it - after last little run up I'd say she looks good, now shes settling I'm thinking to go in for some more and maybe bring some players in. But I have some questions if anyone has the time to answer. Id like to know more as still learning.

1. Youre all talking a deal being very imminent? what evidence do you have for that other than Big pharama cashed up and NEU's drug seems to be at right stage for such. I see no announcements of such or of prelim discussions? so is it just mass speculation or more to it? wheres your imminent deal hysteria comming from?. (hey realistic speculation is ok too- thats what makes markets work) I'm just trying to see if anything more material there?

2. are Bell potter long? 2A) do they have any income flowes now?

3.What basis is the much vaubnted 650 mill valuation on a potential licencing deal based on?. Would that Just be for their drug triofinate (or whatever its called?) and just for one diease? like autism- if it gets used for Retts syndrone for example is that another deal etc or is it expected that will one company buy out their technology for all uses- and what may that be worth in upfront licenecing payment and profit share deal? pls let me know your best guesses.

4. How can the company grow from there post deal?

any more info will help and if it adds up in retrun i'll hope to bring in some decent buying real soon.